{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-24-000054","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.283199+00:00","generated_at":"2026-06-01T04:02:44.303542+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Edwards Lifesciences principal accounting officer Sellers retires; Dahl named successor effective July 1","bullets":["Robert W.A. Sellers, Senior VP and Principal Accounting Officer, retires effective July 1, 2024.","Andrew M. Dahl, currently Senior VP and Corporate Controller, succeeds Sellers as Principal Accounting Officer.","Dahl joined Edwards in February 2024; prior roles include VP at Medtronic and Manager at Deloitte.","No material interest, arrangement, or family relationship exists between Dahl and Edwards officers or directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-24-000054","json":"https://secwatch.observer/filing/0001099800-24-000054.json","markdown":"https://secwatch.observer/filing/0001099800-24-000054.md","text":"https://secwatch.observer/filing/0001099800-24-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/0001099800-24-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/ew-20240614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:02:44.303542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"acd18f0442","claim":"Robert W.A. Sellers departed as Senior Vice President, Principal Accounting Officer at Edwards Lifesciences Corp.","evidence_excerpt":"Robert W.A. Sellers, Senior Vice President, Principal Accounting Officer of the Company, of his decision to retire, effective as of July 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/0001099800-24-000054-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Senior Vice President, Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"b8098f0054","claim":"Andrew M. Dahl was appointed as Principal Accounting Officer at Edwards Lifesciences Corp.","evidence_excerpt":"On the Retirement Date, Mr. Sellers will be succeeded by Andrew M. Dahl, currently Senior Vice President and Corporate Controller of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000054/0001099800-24-000054-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}